RBC Capital Cuts Kratos Price Target to $55 From $80
RBC Capital cut its price target on Kratos from $80 to $55 per share.
Related stories
Dis-Chem Pharmacies Retail Revenue Grew 7.2% Over Seven Weeks
Retail revenue grew 7.2% from September 1 to October 19, 2026.
M impact | EQUITY | Oct 29, 2026, 03:16 PM UTC
Microsoft Plans to Raise at Least $25 Billion in US Bond Offering
Microsoft is seeking to raise at least $25 billion through a US bond offering.
M impact | EQUITY | Oct 29, 2026, 03:16 PM UTC
FTAI Aviation Shares Jump 11.8% After Q3 Results, $500 Million Buyback
FTAI Aviation reported third-quarter 2026 results with double-digit earnings growth and a $500 million accelerated share repurchase program. Its shares rose 11.8% in morning tradin
M impact | EQUITY | Oct 29, 2026, 03:15 PM UTC
Crocs Shares Jump 21.4% After Q3 Results and Revenue Outlook Raise
Crocs shares rose 21.4% in the morning session after the company reported third-quarter 2026 results and raised its full-year revenue growth outlook.
M impact | EQUITY | Oct 29, 2026, 03:15 PM UTC
Quanta Raises Full-Year Guidance After Third-Quarter Earnings
Quanta shares rose 5.4% in morning trading after the company reported third-quarter 2026 earnings that expanded from a year earlier and raised full-year guidance across all metrics
M impact | EQUITY | Oct 29, 2026, 03:15 PM UTC
Dis-Chem Group Revenue Grew 7.9% Over Seven Weeks
Dis-Chem Pharmacies reported group revenue growth of 7.9% for the seven-week period from 1 September to 19 October 2026, versus the prior comparable period.
L impact | EQUITY | Oct 29, 2026, 03:15 PM UTC